Cargando…
Predictive value of RAD51 on the survival and drug responsiveness of ovarian cancer
BACKGROUND: Ovarian cancer has greatly endangered and deteriorated female health conditions worldwide. Refinement of predictive biomarkers could enable patient stratification and help optimize disease management. METHODS: RAD51 expression profile, target-disease associations, and fitness scores of R...
Autores principales: | Feng, Yuchen, Wang, Daoqi, Xiong, Luyang, Zhen, Guohua, Tan, Jiahong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097773/ https://www.ncbi.nlm.nih.gov/pubmed/33952262 http://dx.doi.org/10.1186/s12935-021-01953-5 |
Ejemplares similares
-
Protein expression profiling identifies a prognostic model for ovarian cancer
por: Xiong, Luyang, et al.
Publicado: (2022) -
RAD51 is a potential marker for prognosis and regulates cell proliferation in pancreatic cancer
por: Zhang, Xiaomeng, et al.
Publicado: (2019) -
Expression of PAWR predicts prognosis of ovarian cancer
por: Tan, Jiahong, et al.
Publicado: (2020) -
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D
por: Yang, Xin, et al.
Publicado: (2020) -
RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer
por: Compadre, Amanda J., et al.
Publicado: (2023)